Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
35
Purchases
33
Sales
2
Purchase value
$2.99M
Sale value
$24.58K
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
John a PaganelliDirector
4
Filed Nov 5, 2026Period of report Nov 5, 20260001193125-26-449786
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 5, 2026
Common Stock
4,426
$1.78
$7.88K
389,914
Direct
SaleNov 5, 2026
Common StockF1
9,175
$1.82
$16.70K
0
IndirectSee Footnote
Filing footnotes · 1
F1These securities are owned by Mr. Paganelli's spouse. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.
Filed Mar 20, 2026Period of report Mar 20, 20260001193125-26-117703
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMar 20, 2026
Common Stock
10,000
$1.135
$11.35K
394,340
Direct
Filing footnotes · 1
F1These securities are owned by Mr. Paganelli's spouse. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 21, 2025Period of report Nov 21, 20250001193125-25-291590
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 21, 2025
Common StockF1
102,371
$1.30
$133.08K
216,228,819
IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF1
3,894
$1.32
$5.14K
216,232,713
IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF1
89,375
$1.325
$118.42K
216,322,088
IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF1
191,490
$1.33
$254.68K
216,513,578
IndirectSee Footnote
PurchaseNov 21, 2025
Common StockF1
192,870
$1.335
$257.48K
216,706,448
IndirectSee Footnote
Filing footnotes · 2
F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 20, 2025Period of report Nov 20, 20250001193125-25-290115
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 20, 2025
Common StockF1
119,129
$1.32
$157.25K
215,665,577
IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1
47,105
$1.325
$62.41K
215,712,682
IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1
211,948
$1.33
$281.89K
215,924,630
IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1
161,818
$1.335
$216.03K
216,086,448
IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1
24,579
$1.34
$32.94K
216,111,027
IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1
1,757
$1.345
$2.36K
216,112,784
IndirectSee Footnote
PurchaseNov 20, 2025
Common StockF1
13,664
$1.35
$18.45K
216,126,448
IndirectSee Footnote
Filing footnotes · 2
F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 19, 2025Period of report Nov 19, 20250001193125-25-288284
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 19, 2025
Common StockF1
36,325
$1.28
$46.50K
215,002,773
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
58,160
$1.285
$74.74K
215,060,933
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
300
$1.29
$387.00
215,061,233
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
21,236
$1.295
$27.50K
215,082,469
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
30,082
$1.30
$39.11K
215,112,551
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
12,993
$1.305
$16.96K
215,125,544
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
66,504
$1.31
$87.12K
215,192,048
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
198,904
$1.315
$261.56K
215,390,952
IndirectSee Footnote
PurchaseNov 19, 2025
Common StockF1
155,496
$1.32
$205.25K
215,546,448
IndirectSee Footnote
Filing footnotes · 2
F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Phillip MD et AL FrostDirector · CEO & Chairman · 10% owner
4
Filed Nov 18, 2025Period of report Nov 18, 20250001193125-25-286448
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 18, 2025
Common StockF1
410
$1.245
$510.45
214,386,858
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
49,590
$1.25
$61.99K
214,436,448
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
66,635
$1.255
$83.63K
214,503,083
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
15,000
$1.265
$18.98K
214,564,783
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
1,772
$1.27
$2.25K
214,566,555
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
212,608
$1.275
$271.08K
214,779,163
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
69,728
$1.28
$89.25K
214,848,891
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
428
$1.2847
$549.85
214,849,319
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
83,556
$1.285
$107.37K
214,932,875
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
1
$1.2859
$1.29
214,932,876
IndirectSee Footnote
PurchaseNov 18, 2025
Common StockF1
33,572
$1.29
$43.31K
214,966,448
IndirectSee Footnote
Filing footnotes · 2
F1The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.